EUVIMEDEUVIMED entdecken
Leserbrief

Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories

Teruhiko Imamura iD

Cardiovascular Drugs and Therapy · 17.11.2026

DOI: 10.1007/s10557-026-07990-4 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Cardiovascular Drugs and Therapy, online erschienen am 17.11.2026. Verfasst von Teruhiko Imamura. Beteiligte Einrichtung: Second Department of Internal Medicine, University of Toyama, 2630 Sugitani Toyama, Toyama, 930-0194, Japan. te.imamu@gmail.com. Die Arbeit nennt 3 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Antithrombotic therapyClinical outcomesMajor adverse cardiovascular eventsTransvalvular pressure gradientVave-in-valve transcatheter aortic valve implantation

Autor:innen und Institutionen

  • Second Department of Internal Medicine, University of Toyama, 2630 Sugitani Toyama, Toyama, 930-0194, Japan. te.imamu@gmail.com.

ORCID-Profile: Teruhiko Imamura

Zitieren

APA

Imamura, T. (2026). Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories. Cardiovascular Drugs and Therapy. https://doi.org/10.1007/s10557-026-07990-4

Vancouver

Imamura T. Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories. Cardiovascular Drugs and Therapy. 2026. doi:10.1007/s10557-026-07990-4

BibTeX
@article{Imamura2026,
  author = {Imamura, Teruhiko},
  title = {Interpreting Antithrombotic Outcomes After Valve-in-Valve TAVI: The Importance of Event Timing and Hemodynamic Trajectories},
  journal = {Cardiovascular Drugs and Therapy},
  year = {2026},
  doi = {10.1007/s10557-026-07990-4}
}
Kostenlos starten →